Abuse potential assessment of novel central nervous system active and psychedelic substances for controlled substances act scheduling recommendations.
Journal of Psychopharmacology 2026 Jack E Henningfield, Sandra D Comer, Matthew L Banks et al. 5 citations
Abuse potential assessment of drugs with central nervous system activity is a critical component of the development of new medications for regulatory filings for approval worldwide. These new drug applications typically include recommendations for scheduling status as a controlled substance, if scheduling is warranted. This commentary focuses on the approach and current issues related to...
DOI: 10.1177/02698811251378511 (opens in new tab)
Full text (opens in new tab)
Abuse potential
Novel drugs
Psychedelic